News Archive

Archives: Search / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

2018 Archives

Nov 19, 2018
-- Highest quarterly revenue for SPRIX Nasal Spray and OXAYDO --
Oct 31, 2018
--Anticipates projected pro forma annual net revenue of between $80 and $90 million--
Aug 8, 2018
--Improvements in formulary status for key products--
Jul 25, 2018
Jun 7, 2018
Jun 4, 2018
May 29, 2018
May 8, 2018
--Multiple advances in formulary status for key products--
May 7, 2018
--SPRIX Nasal Spray placed in preferred position--
Apr 30, 2018
Apr 24, 2018
Apr 17, 2018
Mar 21, 2018
Mar 12, 2018
-- 120 percent combined prescription growth 2017 over 2016 --
Feb 28, 2018
Feb 26, 2018
Feb 20, 2018
Feb 1, 2018
Jan 29, 2018
--Data help clinicians interpret abuse-deterrent studies--
Jan 24, 2018
--Attendees to discuss best practices in Category 1 abuse-deterrent studies--
Jan 23, 2018
-- Doubles the promotional effort behind SPRIX --
Jan 3, 2018
 

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2019 Zyla Life Sciences
All rights reserved.